Related Experiment Video

Updated: Jun 28, 2026

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Leukotriene inhibition in small animal medicine

L Goodman1, T B Coles, S Budsberg

  • 1Small Animal Medicine and Surgery, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA. lgoodman@uga.edu

Journal of Veterinary Pharmacology and Therapeutics
|November 13, 2008
PubMed

Insights

Leukotriene inhibition shows therapeutic benefits for inflammatory conditions in humans, with potential applications in veterinary medicine for diseases like osteoarthritis and cancer.

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Inflammation Research

Background:

  • Leukotrienes are key mediators in human inflammatory and allergic conditions.
  • Leukotriene pathways are implicated in tumorigenesis and tumor progression.
  • Leukotriene inhibition has demonstrated efficacy in human clinical trials for osteoarthritis, asthma, and dermatitis.

Purpose of the Study:

  • To summarize leukotriene function and synthesis.
  • To review the therapeutic potential of leukotriene inhibition in human and veterinary medicine.
  • To focus on applications in osteoarthritis, NSAID-induced gastrointestinal damage, asthma, dermatitis, and cancer.

Main Methods:

  • Literature review of leukotriene function, synthesis, and inhibition.
  • Analysis of published data on therapeutic applications in human medicine.
  • Exploration of potential veterinary applications based on human data.

Main Results:

  • Leukotriene inhibition is effective for osteoarthritis, allergic asthma, and atopic dermatitis in humans.
  • Leukotrienes are implicated in cancer development and growth.
  • Significant progress in human therapeutic applications contrasts with limited veterinary research.

Conclusions:

  • Leukotriene inhibition holds promise for treating various inflammatory diseases and cancers in humans.
  • Further research is needed to translate these findings into veterinary therapeutic strategies.
  • Leukotriene inhibition represents a potential, yet underexplored, treatment avenue in veterinary medicine.

More Related Videos

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...